Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 24, 16:00
2623.20
-8.75 (-0.33%)
VOLUME 32,468
LIVE
NSE
Mar 24, 15:54
2628.35
-2.85 (-0.11%)
VOLUME 345,182
Announcements on Dr Reddys Labs

21st-Mar-2017 14:06Source: NSE

Dr. Reddy's Laboratories Limited

The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned "US FDA finds repeat observations from 2015 warning letter. Failed to maintain co...

21st-Mar-2017 12:34Source: BSE

Dr Reddys Labs- Clarifies on News item

With reference to news flashed on ET Now dated March 21, 2017 quoting "US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance." Dr Reddys Labo...

21st-Mar-2017 11:53Source: NSE

Dr. Reddy's Laboratories Limited

The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned "US FDA finds repeat observations from 2015 warning letter. Failed to maintain co...

21st-Mar-2017 10:15Source: BSE

Dr Reddys Labs- Clarification sought from Dr Reddys Laboratories Ltd

The Exchange has sought clarification from Dr Reddys Laboratories Ltd on March 21, 2017, with reference to news flashed on ET Now dated March 21, 2017 quoting "US FDA finds repeat observations from 20...

14th-Mar-2017 14:54Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 8973 Equity Shares under ESOP

14th-Mar-2017 14:44Source: BSE

Dr Reddys Labs- Allotment Of 8,973 Equity Shares On Exercise Of ESOP

This is to inform you that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 8,973 equity shares of Rs.5/- each of the Company, fully paid up, o...

9th-Mar-2017 11:23Source: BSE

Dr Reddys Labs- Completion of Audit of Company's formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA

Dr Reddys Laboratories Ltd has informed BSE that the audit of Company''s formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA, has been completed on March 08, 2017. The Company ha...

6th-Mar-2017 16:24Source: BSE

Dr Reddys Labs- Clarification on Press Release dated March 03, 2017

Dr Reddys Laboratories Ltd has submitted to BSE a copy of Clarification on Press Release made by Company on March 03, 2017 titled ''Dr. Reddy''s Laboratories announces acquisition of 100% stake in Im...

6th-Mar-2017 16:02Source: NSE

Dr. Reddy's Laboratories Limited

DRREDDY:The Exchange had sought clarification from Dr. Reddy''s Laboratories Limited with respect to announcement dated March 03, 2017, regarding a press release dated March 03, 2017, titled "Dr. Redd...

6th-Mar-2017 11:11Source: NSE

Dr. Reddy's Laboratories Limited

DRREDDY:The Exchange has sought clarification from Dr. Reddy''s Laboratories Limited with respect to announcement dated March 03, 2017, regarding a press release dated March 03, 2017, titled "Dr. Redd...

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.